One potential risk that has sparked unease among the medical community is that the new variant may be able to bypass immunity provided by b...

Four out of five companies of 500 surveyed by Aon in May said they are not instituting across-the-board pay cuts. And nearly 70% said they ...

The decision consequently allowed pharma firms Biocon and Mylan to sell their version of Roche's drug for treating two kinds of breast canc...

The companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first ...

Roche has initiated an internal investigation following reports the it had been used in certain eye ailments and damaged the vision of 15 p...

Companies have stepped in to help consumers authenticate the drugs themselves using mobile technology, including these start-ups.

Merck’s competitors have lined up their own immunotherapy drugs. They include Bristol Myers Squibb (BMS), Roche & Novartis & several smalle...

The flexibilities are there and they have never been questioned by anyone in the WTO.

In an interview with ET Now, Bhaskar Narayana, Finance-Director, Natco Pharma, talks about the IPAB’s verdict on Natco’s cancer drug case a...

The hotel tariff went up by 12% in the first 6 months of this yr in the country amid rise in demand for hotel rooms from domestic traveller...

Shares of drug firms Cipla and Lupin surged after news reports surfaced that Takeda Pharmaceutical Co, is in talks to buy either of their p...

Takeda, Japan's largest pharmaceutical firm, has begun talks with two of India's biggest companies for purchasing either of their pharma bu...

The United Arab Emirates’ health ministry has given approval to Neopharma to manufacture a version of flu drug Tamiflu in a joint venture w...

The health ministry is yet to give private labs the go-ahead to test samples for H1N1 swine flu but a price war has already begun among the...

Ranbaxy Laboratories is voluntarily recalling a batch of its best-selling anti-acne drug remaining in the US market that was banned earlier...

Some more good news could be around the corner for cancer patients and healthcare groups campaigning for access to cheaper medicines. A sec...

Discussions are posted by bloggers on ayurveda, biogenerics, combination drugs, patents, HIV as well as individual pharma cos. Scripting In...